GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹9,295 Cr | ₹7,428 Cr | ₹8,424 Cr | ₹8,282 Cr | ₹7,360 Cr |
What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹9,295 Cr |
| Mar2024 | ₹7,428 Cr |
| Mar2023 | ₹8,424 Cr |
| Mar2022 | ₹8,282 Cr |
| Mar2021 | ₹7,360 Cr |
How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,295 Cr | 25.14 | |
| Mar2024 | ₹7,428 Cr | -11.82 | |
| Mar2023 | ₹8,424 Cr | 1.71 | |
| Mar2022 | ₹8,282 Cr | 12.54 | |
| Mar2021 | ₹7,360 Cr | - | |
Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹63,438.6 Cr | 2.6% | -0.7% | 2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 2.6% |
-0.7% |
2.9% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses